LstCAR019
/ Chongqing Precision Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 30, 2022
Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
(clinicaltrials.gov)
- P1/2 | N=0 | Withdrawn | Sponsor: Kunming Hope of Health Hospital | N=30 ➔ 0 | Recruiting ➔ Withdrawn
CAR T-Cell Therapy • Enrollment change • Trial withdrawal • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19
October 07, 2022
Anti-CD19 Universal CAR-T Cells (LstCAR019) for r/r CD19+ B-ALL
(clinicaltrials.gov)
- P1/2 | N=30 | Recruiting | Sponsor: Kunming Hope of Health Hospital
CAR T-Cell Therapy • New P1/2 trial • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19
1 to 2
Of
2
Go to page
1